Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Change in Acquisitions & Divestments (2023 - 2025)

IDEAYA Biosciences' Change in Acquisitions & Divestments history spans 3 years, with the latest figure at $138.9 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 1.48% year-over-year to $138.9 million; the TTM value through Dec 2025 reached $680.2 million, down 1.79%, while the annual FY2025 figure was $680.2 million, 1.79% down from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $138.9 million at IDEAYA Biosciences, down from $180.8 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $234.3 million in Q2 2024 and bottomed at $95.9 million in Q1 2023.
  • The 3-year median for Change in Acquisitions & Divestments is $140.0 million (2024), against an average of $151.1 million.
  • The largest annual shift saw Change in Acquisitions & Divestments skyrocketed 134.88% in 2024 before it fell 25.68% in 2025.
  • A 3-year view of Change in Acquisitions & Divestments shows it stood at $110.5 million in 2023, then grew by 27.63% to $141.0 million in 2024, then fell by 1.48% to $138.9 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Change in Acquisitions & Divestments are $138.9 million (Q4 2025), $180.8 million (Q3 2025), and $174.1 million (Q2 2025).